Deferred Income Tax Expense (Benefit) of Onconetix, Inc. from 31 Dec 2023 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
Onconetix, Inc. annual and quarterly Deferred Income Tax Expense (Benefit) in USD history and change rate from 31 Dec 2023 to 31 Dec 2024.
  • Onconetix, Inc. Deferred Income Tax Expense (Benefit) for the quarter ending 31 Mar 2024 was $121,567.
  • Onconetix, Inc. annual Deferred Income Tax Expense (Benefit) for 2024 was $1,045,181, a 8200% decline from 2023.
Source SEC data
View on sec.gov
Deferred Income Tax Expense (Benefit), Annual (USD)
Deferred Income Tax Expense (Benefit), YoY Annual Change (%)
Deferred Income Tax Expense (Benefit), Quarterly (USD)

Onconetix, Inc. Annual Deferred Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $1,045,181 -$1,032,588 -8200% 01 Jan 2024 31 Dec 2024 10-K 02 Jun 2025 2024 FY
2023 $12,593 01 Jan 2023 31 Dec 2023 10-K 02 Jun 2025 2024 FY

Onconetix, Inc. Quarterly Deferred Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $121,567 01 Jan 2024 31 Mar 2024 10-Q 12 Jun 2025 2025 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.